...
search icon
pypd-img

PolyPid Share Price

PYPD
NAQ
$4.43
-$0.16
(-3.49%)
1D
Industry: Biotechnology Sector: Health Care

PolyPid Analyst Forecast

PolyPid Share Price Chart

PolyPid Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$76.35M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
25.76K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.49
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$2.3 L
$5.12 H
$4.43

About PolyPid, Common Stock

PolyPid Ltd., a clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. It is also developing OncoPLEX, which is in preclinical stage for the treatment of intra-tumoral cancer. The company has a research and development collaboration with ImmunoGenesis, Inc. for the development of formulations to treat solid tumors. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel. more

Industry: BiotechnologySector: Health Care

PolyPid Stock Returns

Time FramePYPDSectorS&P500
1-Week Return-1.99%-1.08%-1.38%
1-Month Return0.45%-0.47%-1.81%
3-Month Return23.74%2.13%1.38%
6-Month Return26.93%17.04%5.68%
1-Year Return56.48%6.56%11.74%
3-Year Return-80.77%16.78%65.15%
5-Year Return-99.01%34.34%73.68%
10-Year Return-99.22%137.88%260.03%

PolyPid Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue1.01M1.12M1.72M1.82M1.62M[{"date":"2020-12-31","value":55.54,"profit":true},{"date":"2021-12-31","value":61.36,"profit":true},{"date":"2022-12-31","value":94.46,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":89.02,"profit":true}]
Gross Profit(1.01M)(1.12M)(1.72M)(1.82M)(1.62M)[{"date":"2020-12-31","value":-101200000,"profit":false},{"date":"2021-12-31","value":-111800000,"profit":false},{"date":"2022-12-31","value":-172100000,"profit":false},{"date":"2023-12-31","value":-182200000,"profit":false},{"date":"2024-12-31","value":-162200000,"profit":false}]
Gross Margin-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses26.27M42.88M38.89M22.87M28.03M[{"date":"2020-12-31","value":61.28,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":90.7,"profit":true},{"date":"2023-12-31","value":53.33,"profit":true},{"date":"2024-12-31","value":65.37,"profit":true}]
Operating Income(26.27M)(42.88M)(38.89M)(22.87M)(28.03M)[{"date":"2020-12-31","value":-2627200000,"profit":false},{"date":"2021-12-31","value":-4287500000,"profit":false},{"date":"2022-12-31","value":-3888800000,"profit":false},{"date":"2023-12-31","value":-2286700000,"profit":false},{"date":"2024-12-31","value":-2802900000,"profit":false}]
Total Non-Operating Income/Expense(21.19M)1.09M(1.08M)(1.94M)(1.90M)[{"date":"2020-12-31","value":-1947.98,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-99.26,"profit":false},{"date":"2023-12-31","value":-178.49,"profit":false},{"date":"2024-12-31","value":-174.82,"profit":false}]
Pre-Tax Income(36.87M)(42.33M)(39.43M)(23.80M)(28.98M)[{"date":"2020-12-31","value":-3686900000,"profit":false},{"date":"2021-12-31","value":-4233100000,"profit":false},{"date":"2022-12-31","value":-3942800000,"profit":false},{"date":"2023-12-31","value":-2379600000,"profit":false},{"date":"2024-12-31","value":-2898000000,"profit":false}]
Income Taxes(1.54M)(1.62M)97.00K69.00K42.00K[{"date":"2020-12-31","value":-1592.78,"profit":false},{"date":"2021-12-31","value":-1668.04,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":71.13,"profit":true},{"date":"2024-12-31","value":43.3,"profit":true}]
Income After Taxes(35.32M)(40.71M)(39.52M)(23.86M)(29.02M)[{"date":"2020-12-31","value":-3532400000,"profit":false},{"date":"2021-12-31","value":-4071300000,"profit":false},{"date":"2022-12-31","value":-3952500000,"profit":false},{"date":"2023-12-31","value":-2386500000,"profit":false},{"date":"2024-12-31","value":-2902200000,"profit":false}]
Income From Continuous Operations(36.87M)(42.33M)(39.52M)(24.08M)(29.02M)[{"date":"2020-12-31","value":-3686900000,"profit":false},{"date":"2021-12-31","value":-4233100000,"profit":false},{"date":"2022-12-31","value":-3952500000,"profit":false},{"date":"2023-12-31","value":-2407600000,"profit":false},{"date":"2024-12-31","value":-2902200000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(35.32M)(40.71M)(39.52M)(23.86M)(29.02M)[{"date":"2020-12-31","value":-3532400000,"profit":false},{"date":"2021-12-31","value":-4071300000,"profit":false},{"date":"2022-12-31","value":-3952500000,"profit":false},{"date":"2023-12-31","value":-2386500000,"profit":false},{"date":"2024-12-31","value":-2902200000,"profit":false}]
EPS (Diluted)(214.22)(68.10)(61.20)(26.44)(4.91)[{"date":"2020-12-31","value":-21422.5,"profit":false},{"date":"2021-12-31","value":-6810,"profit":false},{"date":"2022-12-31","value":-6120,"profit":false},{"date":"2023-12-31","value":-2644,"profit":false},{"date":"2024-12-31","value":-491,"profit":false}]

PolyPid Ratios

PolyPid Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

PYPD
Cash Ratio 2.49
Current Ratio 2.57

PolyPid Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

PYPD
ROA (LTM) -86.71%
ROE (LTM) -366.29%

PolyPid Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

PYPD
Debt Ratio Lower is generally better. Negative is bad. 0.43
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.57

PolyPid Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

PYPD
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 4.97
EV/R 0.00
EV/Ebitda NM

FAQs

What is PolyPid share price today?

PolyPid (PYPD) share price today is $4.43

Can Indians buy PolyPid shares?

Yes, Indians can buy shares of PolyPid (PYPD) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in PYPD stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of PolyPid be purchased?

Yes, you can purchase fractional shares of PolyPid (PYPD) via the Vested app. You can start investing in PolyPid (PYPD) with a minimum investment of $1.

How to invest in PolyPid shares from India?

You can invest in shares of PolyPid (PYPD) via Vested in three simple steps:

  • Click on Sign Up or Invest in PYPD stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in PolyPid shares
What is PolyPid 52-week high and low stock price?

The 52-week high price of PolyPid (PYPD) is $5.12. The 52-week low price of PolyPid (PYPD) is $2.3.

What is PolyPid price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of PolyPid (PYPD) is

What is PolyPid price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of PolyPid (PYPD) is 4.97

What is PolyPid dividend yield?

The dividend yield of PolyPid (PYPD) is 0.00%

What is the Market Cap of PolyPid?

The market capitalization of PolyPid (PYPD) is $76.35M

What is PolyPid's stock symbol?

The stock symbol (or ticker) of PolyPid is PYPD

How Can Investors Use PolyPid Share Price Data for Long-Term Investment Decisions?

Consider the share price of PolyPid as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether PolyPid has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from PolyPid shares for Indian investors?

When investing in PolyPid shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the PolyPid stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare PolyPid share price with other stocks in the same sector?

Rather than merely checking the share price of PolyPid and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that PolyPid stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top